Drug-coated balloon comparison for heart attack treatment
Part of Heart & circulation clinical trials.
This trial compares two types of special balloons coated with different medications to treat blocked heart arteries in patients with acute heart attacks. The goal is to see which coating works better to keep the artery open and prevent future blockages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80 years old
- Recent heart attack (non-STEMI) or unstable chest pain with a blocked artery suitable for balloon treatment
- Blocked artery segment is small (≤28mm long) and medium-sized (2.5–3.0mm wide)
- Artery successfully opened with initial balloon inflation, with minimal remaining blockage (≤30%)
- No severe kidney disease or active dialysis
- No allergies to aspirin, clopidogrel, contrast dye, paclitaxel, sirolimus, or related medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is comparing sirolimus and paclitaxel drug-coated balloons to treat new blockages or restenosis (re-blockage) in heart arteries. It aims to see which type of balloon works better for opening arteries without leaving a metal stent behind.
This study tests a drug-coated balloon (DCB) that releases two medicines (sirolimus and paclitaxel) to open blocked small heart arteries. It may help people with stable chest pain or recent, controlled heart events who have a narrowed small vessel.
This trial tests a special balloon coated with medicine to treat plaque erosion, which is a common cause of heart attacks. The balloon delivers the drug directly to the narrowed artery, potentially reducing the need for a stent.
This study compares two types of balloon catheters used to open blocked heart arteries during a heart attack. It aims to see if a special coated balloon is safer and more effective than the standard one, using advanced imaging to guide the procedure.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
This trial is studying how well drug-coated balloons work for people with coronary artery disease. It looks at their use in many different situations, including new blockages, re-narrowed stents, and complex cases. The goal is to see if they are a good option for opening blocked arteries.
Hear when a new Acute Coronary Syndromes (ACS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.